Liana K. Billings
Endocrinology | Medical Genetics
9977 Woods Dr.
Suite 300
Skokie, IL 60077
Suite 300
Skokie, IL 60077
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Journal: Lancet (London, England)
Published: April 17, 2026
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.
Journal: The lancet. Diabetes & endocrinology
Published: April 02, 2026
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome.
Journal: Diabetes, obesity & metabolism
Published: December 04, 2025
Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 19, 2025
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: September 29, 2025
Web Exclusive. Annals On Call - Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control Is Inadequate With Dulaglutide.
Journal: Annals of internal medicine
Published: August 04, 2025
Disparities and trends in pulmonary embolism mortality with and without obesity: a nationwide US analysis.
Journal: Research and practice in thrombosis and haemostasis
Published: June 03, 2025
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide : A Randomized Clinical Trial.
Journal: Annals of internal medicine
Published: April 04, 2025
Envisioning Tools to Help Classify Type 1 Diabetes and Type 2 Diabetes in New-Onset Adult Diabetes.
Journal: Journal of diabetes science and technology
Published: March 28, 2025
Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT).
Journal: Journal of diabetes science and technology
Published: January 09, 2025
Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: A retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease.
Journal: Diabetes research and clinical practice
Published: December 12, 2024
AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: October 25, 2024
Last Updated: 09/26/2026